Patents by Inventor Ghaleb Daouk

Ghaleb Daouk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of creatine or creatine analogs for the treatment of diseases of the nervous system
    Publication number: 20080119450
    Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.
    Type: Application
    Filed: September 4, 2007
    Publication date: May 22, 2008
    Applicants: AVICENA GROUP, INC., The General Hospital Corporation
    Inventors: Rima Kaddurah-Daouk, Ghaleb Daouk, M. Flint Beal
  • Use of creatine or creatine analogs for the treatment of diseases of the nervous system
    Patent number: 7285573
    Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: October 23, 2007
    Assignees: Avicena Group, Inc., The General Hospital Corp.
    Inventors: Rima Kaddurah-Daouk, Ghaleb Daouk, M. Flint Beal
  • Use of creatine or creatine analogs for the treatment of diseases of the nervous system
    Publication number: 20040106680
    Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.
    Type: Application
    Filed: November 21, 2003
    Publication date: June 3, 2004
    Applicants: AVICENA GROUP, INC., The General Hospital Corporation
    Inventors: Rima Kaddurah-Daouk, Ghaleb Daouk, M. Flint Beal
  • Use of creatine or creatine analogs for the treatment of diseases of the nervous system
    Publication number: 20040102419
    Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.
    Type: Application
    Filed: November 21, 2003
    Publication date: May 27, 2004
    Applicants: AVICENA GROUP, INC., The General Hospital Corporation
    Inventors: Rima Kaddurah-Daouk, Ghaleb Daouk, M. Flint Beal
  • Use of creatine or creatine analogs for the treatment of diseases of the nervous system
    Patent number: 6706764
    Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: March 16, 2004
    Assignees: Avicena Group, Inc., The General Hospital Corporation
    Inventors: Rima Kaddurah-Daouk, Ghaleb Daouk, M. Flint Beal
  • USE OF CREATINE OR CREATINE ANALOGS FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSYEM
    Publication number: 20020161049
    Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer disease, Parkinson's disease, stroke, Huntington's disease, amyotropic lateral sclerosis, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases.
    Type: Application
    Filed: May 7, 1997
    Publication date: October 31, 2002
    Inventors: RIMA KADDURAH-DAOUK, GHALEB DAOUK, M. FLINT BEAL